Immatics (IMTX) Non Operating Income (2019 - 2025)
Immatics' (IMTX) quarterly Non Operating Income came in at $3.9 million in Q4 2025, down 91.47% year-on-year from $45.3 million in Q4 2024, and down 16.62% quarter-over-quarter from $4.6 million in Q3 2025.
Immatics (IMTX) Non Operating Income (2019 - 2025) Analysis & Trends
Immatics has disclosed Non Operating Income across 7 years of filings, most recently posting $3.9 million for Q4 2025.
- Non Operating Income for Q4 2025 came in at $3.9 million, down 91.47% year-over-year; the trailing twelve-month figure through Dec 2025 was -$17.9 million (down 127.84% YoY), and the FY2025 annual result was -$18.6 million, down 128.95% from the prior year.
- Non Operating Income came in at $3.9 million for Q4 2025 at Immatics, down from $4.6 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $45.3 million in Q4 2024 to a low of -$20.6 million in Q2 2025.
- The 5-year median for Non Operating Income is $1.6 million (2022), against an average of $2.9 million.
- Across the five-year window, Non Operating Income sank 1182.94% in 2022 and soared 2587.02% in 2024, its largest moves.
- Immatics' Non Operating Income stood at -$831666.9 in 2021, then tumbled by 1182.94% to -$10.7 million in 2022, then jumped by 115.79% to $1.7 million in 2023, then jumped by 2587.02% to $45.3 million in 2024, then plunged by 91.47% to $3.9 million in 2025.
- The last three Non Operating Income figures came in at $3.9 million (Q4 2025), $4.6 million (Q3 2025), and -$20.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.86 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | -20.63 Mn |
| Mar 31, 2025 | -5.76 Mn |
| Dec 31, 2024 | 45.27 Mn |
| Sep 30, 2024 | -3.15 Mn |
| Jun 30, 2024 | 9.38 Mn |
| Mar 31, 2024 | 12.76 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | -11.21 Mn |
| Mar 31, 2023 | 7.17 Mn |
| Dec 31, 2022 | -10.67 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 4.08 Mn |
| Mar 31, 2022 | 19.27 Mn |
| Dec 31, 2021 | -831,666.88 |
| Sep 30, 2021 | -4.96 Mn |
| Jun 30, 2021 | -3.78 Mn |
| Mar 31, 2021 | 1.24 Mn |